Resistance exercise for protection against glucocorticoids in aged skeletal muscle
抗阻运动可保护老年骨骼肌免受糖皮质激素的影响
基本信息
- 批准号:10449878
- 负责人:
- 金额:$ 7.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectArthritisCancerousCategoriesCell physiologyComplexContralateralDNA receptorDataDexamethasoneDiagnosisElderlyElectric StimulationEventExerciseFrequenciesGene ExpressionGenesGenomeGlucocorticoid ReceptorGlucocorticoidsHealthHormonesHumanIndividualInsulinInsulin ResistanceKnowledgeLifeMalignant NeoplasmsMeasuresMediatingMetabolicMissionModelingMusMuscleMuscle WeaknessMuscular AtrophyMyopathyNuclearNuclear TranslocationOrganismOutcomePathway AnalysisPhosphorylationPilot ProjectsPopulationProcessProteinsPublic HealthPublicationsRNARandomizedReceptor ActivationRecoveryResearchResistanceResistance ProcessResponse ElementsSignal TransductionSkeletal MuscleStimulusSymptomsTherapeuticTherapeutic GlucocorticoidTimeUnited States National Institutes of HealthVulnerable PopulationsWorkagedbasedisabilityfallsglucocorticoid receptor alphahuman old age (65+)muscle agingolder patientpreventpromoterprotective effectreceptorresistance exerciseresponsesciatic nervetibialis anterior muscletranscriptome sequencingtumor
项目摘要
Project Summary/Abstract
Glucocorticoid myopathy is the most common noninflammatory myopathy affecting ~60% of those with
elevated glucocorticoids. Glucocorticoid myopathy is diagnosed by muscle atrophy and weakness; however,
the myopathy includes other symptoms such as insulin resistance. The elderly are particularly vulnerable to the
myopathy as aged muscle is more sensitive to glucocorticoids, endogenous glucocorticoid levels are increased
more than 50% in the elderly, and therapeutic glucocorticoids that treat conditions like arthritis and cancer are
most prevalent in the elderly. While it is known that glucocorticoid myopathy is most prevalent in the elderly,
there are a lack of treatments to prevent the myopathy in this highly vulnerable population. Our recent
publication suggests resistance exercise could be an immediate way to protect aged muscle from
glucocorticoid myopathy. Specifically, we show that a bout of resistance exercise in young muscle reduces
nuclear translocation of the glucocorticoid receptor, a critical step in the process by which glucocorticoids
initiate myopathy. The ability of resistance exercise to blunt nuclear translocation by is particularly important for
the elderly because activation of the receptor induces a more severe myopathy in aged muscle. Also important
for the elderly population, we show that receptor translocation is reduced in the post exercise recovery period,
suggesting that a single bout of resistance exercise could have a lasting protective effect against
glucocorticoids. A muscle targeted approach like resistance exercise will also allow elderly patients taking
prescription glucocorticoids to keep getting therapeutic benefits of the hormone in non-muscle tissue (e.g.
cancerous tumor). In extension of that work, our preliminary data show that a bout of resistance exercise can
prevent the glucocorticoid-induced change in the expression of some target genes, while others appear
resistant to the exercise stimulus. Because the elderly are so vulnerable to glucocorticoid myopathy, and
because glucocorticoids influence expression of up to 20% of the genome, it is important to understand the
capacity of resistance exercise to blunt the signals that initiate glucocorticoid myopathy in aged muscle so that
clinicians can clinicians more effectively treat these elderly patients. Thus, the objective of this proposal is to
define the therapeutic potential of resistance exercise to mitigate processes that initiate glucocorticoid
myopathy in aged skeletal muscle. SPECIFIC AIM 1 will Define the steps within the glucocorticoid receptor
activation process where resistance exercise imparts disruption in young and aged muscle. SPECIFIC AIM 2
will classify and characterize the glucocorticoid target genes in young and aged muscle based upon how a
bout of resistance exercise affects hormone-regulated gene expression. This pilot study will define the extent
to which resistance exercise can blunt the signals that initiate glucocorticoid myopathy in aged skeletal muscle.
These outcomes are significant because they will provide key information for clinicians to effectively use
resistance exercise as part of a comprehensive strategy to prevent glucocorticoid myopathy in the elderly.
项目总结/摘要
糖皮质激素性肌病是最常见的非炎症性肌病,影响约60%的患者,
糖皮质激素升高糖皮质激素肌病的诊断是肌肉萎缩和无力;然而,
肌病包括其它症状,例如胰岛素抵抗。老年人特别容易受到
肌病是由于老年肌肉对糖皮质激素更敏感,内源性糖皮质激素水平增加,
在老年人中超过50%,治疗关节炎和癌症等疾病的治疗性糖皮质激素
最常见于老年人。虽然已知糖皮质激素肌病在老年人中最普遍,
在这个高度脆弱的人群中缺乏预防肌病的治疗。我们最近
一份出版物表明,阻力运动可能是一种直接的方法,以保护老化的肌肉,
糖皮质激素肌病具体来说,我们表明,一轮阻力运动在年轻的肌肉减少
糖皮质激素受体的核转位是糖皮质激素
启动肌病。抗阻运动钝化细胞核转位的能力对
因为受体的激活在老年肌肉中诱导更严重的肌病。同样重要
对于老年人群,我们发现受体易位在运动后恢复期减少,
这表明,一次抗阻运动可能对抵抗运动有持久的保护作用。
糖皮质激素像阻力运动这样的肌肉靶向方法也可以让老年患者服用
处方糖皮质激素,以保持在非肌肉组织(例如,
癌性肿瘤)。在这项工作的延伸,我们的初步数据显示,一轮阻力运动可以
阻止糖皮质激素诱导的一些靶基因表达的变化,而另一些则出现
抵抗运动刺激。因为老年人很容易患上糖皮质激素性肌病,
由于糖皮质激素影响高达20%的基因组表达,因此了解糖皮质激素的作用是很重要的。
抗阻运动减弱老年肌肉中引发糖皮质激素肌病的信号的能力,
临床医生可以更有效地治疗这些老年患者。因此,本提案的目的是
确定抗阻运动的治疗潜力,以减轻启动糖皮质激素的过程
老年骨骼肌肌病特定目的1将定义糖皮质激素受体内的步骤
抗阻运动对年轻和老年肌肉造成破坏的激活过程。具体目标2
将根据年轻和老年肌肉中糖皮质激素靶基因的表达情况,
一次抗阻运动会影响运动调节基因的表达。这项试点研究将确定
抗阻运动可以减弱老年骨骼肌中引发糖皮质激素肌病的信号。
这些结果意义重大,因为它们将为临床医生提供有效使用的关键信息
抗阻运动作为预防老年人糖皮质激素性肌病综合策略的一部分。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bradley S Gordon其他文献
Bradley S Gordon的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bradley S Gordon', 18)}}的其他基金
Resistance exercise to mitigate glucocorticoid myopathy during Alzheimer’s
抗阻运动可减轻阿尔茨海默病期间的糖皮质激素肌病
- 批准号:
10667849 - 财政年份:2023
- 资助金额:
$ 7.43万 - 项目类别:
Resistance exercise for protection against glucocorticoids in aged skeletal muscle
抗阻运动可保护老年骨骼肌免受糖皮质激素的影响
- 批准号:
10615777 - 财政年份:2022
- 资助金额:
$ 7.43万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
- 批准号:
MR/Y009681/1 - 财政年份:2024
- 资助金额:
$ 7.43万 - 项目类别:
Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
- 批准号:
MR/Y022947/1 - 财政年份:2024
- 资助金额:
$ 7.43万 - 项目类别:
Research Grant
Preclinical development of an extracellular vesicle biotherapeutic for juvenile idiopathic arthritis
幼年特发性关节炎细胞外囊泡生物治疗药物的临床前开发
- 批准号:
10068495 - 财政年份:2024
- 资助金额:
$ 7.43万 - 项目类别:
Collaborative R&D
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 7.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Exploring the inflammatory mediators degraded by MMP-2 in MMP-2-deficient mice with knee arthritis through a novel TMT-TAILS quantitative proteomics
通过新型 TMT-TAILS 定量蛋白质组学探索 MMP-2 缺陷型膝关节炎小鼠中 MMP-2 降解的炎症介质
- 批准号:
24K19850 - 财政年份:2024
- 资助金额:
$ 7.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
- 批准号:
491810 - 财政年份:2023
- 资助金额:
$ 7.43万 - 项目类别:
Operating Grants
The role of diet, as mediated by the gut microbiome, on childhood arthritis disease activity: a feasibility intervention study.
肠道微生物组介导的饮食对儿童关节炎疾病活动的作用:一项可行性干预研究。
- 批准号:
489316 - 财政年份:2023
- 资助金额:
$ 7.43万 - 项目类别:
Operating Grants
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
- 批准号:
EP/Y027760/1 - 财政年份:2023
- 资助金额:
$ 7.43万 - 项目类别:
Fellowship
Investigation of hypoxia-inducible factor-1 (HIF-1) as a novel therapeutic target for juvenile idiopathic arthritis.
研究缺氧诱导因子-1 (HIF-1) 作为幼年特发性关节炎的新治疗靶点。
- 批准号:
23K14987 - 财政年份:2023
- 资助金额:
$ 7.43万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 7.43万 - 项目类别: